News _________________________________________
Better surgery worth repeating
Friday, 20 November 2009
Clinical Ontological Society of Australia
istock_operation-2.jpg
Keyhole surgery has improved in recent
years, making repeat surgery more viable.
Image: iStockphoto

New research showing repeat surgery can improve survival and quality of life for brain cancer patients is expected to spark wide debate following its presentation today (19/11) at a national cancer conference.

Sydney neurosurgeon Dr Charlie Teo, said the research, presented at the Clinical Oncological Society of Australia (COSA) Annual Scientific Meeting, challenged conventional wisdom that additional surgery offered no survival benefit and could impact negatively on quality of life.

“Up until a few years ago, there was no rationale to do repeat surgery because pretty much every patient would die as quickly or more quickly than if they didn’t have the extra surgery, sometimes on the operating table,” Dr Teo said.

“However, keyhole surgery has advanced rapidly in recent years and this latest study clearly demonstrates that we can extend survival for most patients and achieve improved quality of life.”

Dr Teo said the restrospective study looked at 96 patients who had previously been operated on for the most common form of brain cancer and then underwent repeat surgery.

The study found functional status was stable or improved in 68 per cent of cases and that the procedure was safe - all patients survived with low rates of complication (14 per cent) and temporary deficit (34 per cent).

Dr Teo said the research added to a growing evidence base that repeat surgery and aggressive keyhole surgery generally should be recommended for a significant number of patients who currently were not given the option.

“This research will challenge standard practice,” he said. “The question is whether clinicians are prepared to look at it seriously and give their patients who could benefit the choice.”

Chair of the COSA’s Brain Guidelines Group, Professor Michael Barton, said there was good evidence that repeat surgery with intra-cranial chemotherapy improved survival.

“We know this type of surgery is effective, however neurosurgeons have yet to adopt it,” he said.


Editor's Note: Original news release can be found here (PDF).
 
| | More

Have You Read These Related Stories? ____________________________________________